ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

RXST RxSight Inc

55.68
-1.39 (-2.44%)
Last Updated: 19:06:35
Delayed by 15 minutes
Share Name Share Symbol Market Type
RxSight Inc NASDAQ:RXST NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.39 -2.44% 55.68 55.63 55.92 57.33 55.2473 57.07 110,201 19:06:35

RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 

14/02/2024 9:05pm

GlobeNewswire Inc.


RxSight (NASDAQ:RXST)
Historical Stock Chart


From Dec 2023 to Jun 2024

Click Here for more RxSight Charts.

(NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the fourth quarter and full year 2023 after the market close on Wednesday, February 28, 2024. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Participants may register for the call here and listen through a live and archived webcast of the event available for one year at https://investors.rxsight.com/. While not required, it is recommended that participants join ten minutes prior to the event start time to ensure the necessary audio applications are downloaded and installed. Instructions are provided (including a dial-in option).

About RxSight, Inc.RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.

Company Contact:Shelley B. ThunenChief Financial Officersthunen@rxsight.com

Investor Relations Contact:Oliver MoravcevicVP, Investor Relationsomoravcevic@rxsight.com

1 Year RxSight Chart

1 Year RxSight Chart

1 Month RxSight Chart

1 Month RxSight Chart

Your Recent History

Delayed Upgrade Clock